AbbVie Brings 730 Jobs, $1.4B to Durham Manufacturing Hub

Durham just landed one of the biggest economic wins in its history, and it's going to change lives both locally and far beyond.

Pharmaceutical giant AbbVie announced plans to build a massive $1.4 billion manufacturing campus in Durham County, creating 734 jobs with an average salary of $118,000. The 185-acre facility will produce cutting-edge medicines for immunology, neuroscience, and oncology, with possible obesity drug production down the line.

"This represents a significant milestone for AbbVie as our largest capital investment to date," said CEO Robert A. Michael. The company chose Durham over its hometown Chicago area, citing the region's exceptional workforce and research capabilities.

Construction starts this year on what will become one of North Carolina's crown jewels in the life sciences sector. The first phase includes manufacturing facilities, laboratories, a warehouse, administrative offices, and employee wellness centers. The campus is designed with room to grow, signaling AbbVie's long-term commitment to the community.

The jobs are exactly the kind that build strong communities. Engineers, scientists, manufacturing operators, and laboratory technicians will fill positions paying 15% above Durham County's average wage. Hiring will continue through 2031, giving the region years of sustained economic growth.

The Ripple Effect

Durham's win creates waves far beyond the 730 direct jobs. More than 2,000 construction workers will build the campus between now and its expected 2028 completion. State economists project the facility will pump $8.1 billion into North Carolina's economy over the next 12 years.

The project elevates North Carolina into rare company. With AbbVie's arrival, the state becomes home to eight of the world's ten largest pharmaceutical companies by revenue. That clustering effect attracts even more talent, investment, and innovation to the region.

Mayor Leonardo Williams called it "a powerful signal that our city is competing and winning on a global stage." He's right. Durham beat out major metropolitan areas because of what the community has built: world-class universities, a thriving biotech ecosystem, and a skilled workforce ready for the future.

State and local governments approved about $51 million in combined incentives to seal the deal. The investment pays workers back many times over through salaries, tax revenue, and the indirect jobs created when 730 high-earning families spend money in their community.

AbbVie's commitment represents more than buildings and balance sheets. The medicines produced in Durham will treat patients fighting serious diseases across the country and around the world. Every pill manufactured there carries Durham's contribution to global health forward.

North Carolina Governor Josh Stein summed up the moment perfectly: "When you combine our world-renowned research and innovation with a strong, thriving life sciences hub, North Carolina quickly becomes the premier location for biopharmaceutical companies to do business."

Durham just proved he's absolutely right.